Exodus Point Capital Management, LP Krystal Biotech, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 18,272 shares of KRYS stock, worth $3.25 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,272
Previous 27,750
34.15%
Holding current value
$3.25 Million
Previous $3.22 Million
0.99%
% of portfolio
0.02%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding KRYS
# of Institutions
262Shares Held
21.5MCall Options Held
462KPut Options Held
723K-
Avoro Capital Advisors LLC New York, NY2.56MShares$454 Million5.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$432 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$321 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.51MShares$268 Million10.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$176 Million9.23% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.56B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...